Clinical Trial Update: Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy [NA]

View source ↗

Summary

A clinical trial investigating a minimally invasive D2+PAND gastrectomy for gastric cancer with PAN metastasis after conversion immunochemotherapy; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Cancer | NA | Status: RECRUITING